{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:24:08Z","timestamp":1791869048917,"version":"4.3.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-023-03095-8","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T08:04:27Z","timestamp":1679645067000},"page":"2153-2168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Radiation therapy for vulvar cancer: consensus guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 1: clinical recommendations"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7036-2160","authenticated-orcid":false,"given":"Sofia","family":"Cordoba Largo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4376-070X","authenticated-orcid":false,"given":"Isabel","family":"Rodriguez Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4415-6563","authenticated-orcid":false,"given":"Silvia","family":"Rodriguez Villalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7815-2870","authenticated-orcid":false,"given":"Dina","family":"Najjari Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5421-9230","authenticated-orcid":false,"given":"Javier","family":"Anchuelo Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0708-5938","authenticated-orcid":false,"given":"Francisco","family":"Celada \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9373-9845","authenticated-orcid":false,"given":"Sonia","family":"Garcia Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"de la Fuente Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Couselo Paniagua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-8703","authenticated-orcid":false,"given":"Irene","family":"Mart\u00ednez Montesinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-4395","authenticated-orcid":false,"given":"Elena","family":"Villafranca Iturre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7726-2338","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Belinch\u00f3n Olmeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Farga Albiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Andrea","family":"Navarrete Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3630-4757","authenticated-orcid":false,"given":"Mar\u00eda","family":"S\u00e1nchez Belda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"GINECOR (Spanish Gynaecological Tumors Group of SEOR)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"issue":"3","key":"3095_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660. (Epub 2021 Feb 4. PMID: 33538338).","journal-title":"CA Cancer J Clin"},{"key":"3095_CR2","unstructured":"WHO Classification of Tumours Editorial Board. Female genital tumours. WHO classification of tumours, 5th edn. IARC; 2020. pp. 419\u2013449. ISBN: 978-92-832-4504-9."},{"key":"3095_CR3","unstructured":"Kurman RJ, Carcangui ML, Herrington CS. WHO classification of tumours of female reproductive organs, chapter 9. Tumours of the vulva. Lyon: IARC; 2014. pp. 232\u20135."},{"issue":"9","key":"3095_CR4","doi-asserted-by":"publisher","first-page":"e0204162","DOI":"10.1371\/journal.pone.0204162","volume":"13","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhang Y, Zhang Z. Prevalence of human papillomavirus and its prognostic value in vulvar cancer: a systematic review and meta-analysis. PLoS ONE. 2018;13(9):e0204162. https:\/\/doi.org\/10.1371\/journal.pone.0204162. (PMID: 30256833; PMCID: PMC6157864).","journal-title":"PLoS ONE"},{"issue":"2","key":"3095_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ygyno.2019.05.010","volume":"154","author":"NC Te Grootenhuis","year":"2019","unstructured":"Te Grootenhuis NC, Pouwer AW, de Bock GH, Hollema H, Bulten J, van der Zee AGJ, et al. Margin status revisited in vulvar squamous cell carcinoma. Gynecol Oncol. 2019;154(2):266\u201375. https:\/\/doi.org\/10.1016\/j.ygyno.2019.05.010. (Epub 2019 May 18. PMID: 31109660).","journal-title":"Gynecol Oncol"},{"issue":"6","key":"3095_CR6","first-page":"733","volume":"68","author":"HD Homesley","year":"1986","unstructured":"Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol. 1986;68(6):733\u201340 (PMID: 3785783).","journal-title":"Obstet Gynecol"},{"issue":"32","key":"3095_CR7","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1200\/JCO.21.00006","volume":"39","author":"MHM Oonk","year":"2021","unstructured":"Oonk MHM, Slomovitz B, Baldwin PJW, van Doorn HC, van der Velden J, de Hullu JA, et al. Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II. J Clin Oncol. 2021;39(32):3623\u201332. https:\/\/doi.org\/10.1200\/JCO.21.00006. (Epub 2021 Aug 25. PMID: 34432481; PMCID: PMC8577685).","journal-title":"J Clin Oncol"},{"issue":"4","key":"3095_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3802\/jgo.2014.25.4.272","volume":"25","author":"AM Aragona","year":"2014","unstructured":"Aragona AM, Soderini AH, Cuneo NA. Defining the concept of locally advanced squamous cell carcinoma of the vulva: a new perspective based on standardization of criteria and current evidence. J Gynecol Oncol. 2014;25(4):272\u20138. https:\/\/doi.org\/10.3802\/jgo.2014.25.4.272. (Epub 2014 Jul 6. PMID: 25142626; PMCID: PMC4195295).","journal-title":"J Gynecol Oncol."},{"issue":"4","key":"3095_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/s0360-3016(00)00762-8","volume":"48","author":"GS Montana","year":"2000","unstructured":"Montana GS, Thomas GM, Moore DH, Saxer A, Mangan CE, Lentz SS, et al. Preoperative chemo-radiation for carcinoma of the vulva with N2\/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2000;48(4):1007\u201313. https:\/\/doi.org\/10.1016\/s0360-3016(00)00762-8. (PMID: 11072157).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3095_CR10","unstructured":"Hamm U, El. Chichajli B. A global vision for the bioeconomy\u2014an international Delphi-Study. Berlin: Bio\u00f6konomierat; 2015."},{"issue":"4","key":"3095_CR11","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","volume":"32","author":"F Hasson","year":"2000","unstructured":"Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32(4):1008\u201315 (PMID: 11095242).","journal-title":"J Adv Nurs"},{"issue":"7","key":"3095_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","volume":"66","author":"J Andrews","year":"2013","unstructured":"Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al. GRADE guidelines: Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66(7):719\u201325. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.03.013. (Epub 2013 Jan 9. PMID: 23312392).","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"3095_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026. (Epub 2010 Dec 31. PMID: 21195583).","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"3095_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Sch\u00fcnemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401\u20136. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.015. (Epub 2011 Jan 5. PMID: 21208779).","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"3095_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF03323881","volume":"1","author":"LZ Rubenstein","year":"1989","unstructured":"Rubenstein LZ, Siu AL, Wieland D. Comprehensive geriatric assessment: toward understanding its efficacy. Aging (Milano). 1989;1(2):87\u201398. https:\/\/doi.org\/10.1007\/BF03323881. (PMID: 2488312).","journal-title":"Aging (Milano)"},{"issue":"24","key":"3095_CR16","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1200\/JCO.2014.57.4822","volume":"32","author":"SM Lichtman","year":"2014","unstructured":"Lichtman SM, Hurria A, Jacobsen PB. Geriatric oncology: an overview. J Clin Oncol. 2014;32(24):2521\u20132. https:\/\/doi.org\/10.1200\/JCO.2014.57.4822. (PMID: 25513235).","journal-title":"J Clin Oncol"},{"key":"3095_CR17","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Montalvo JI, Ram\u00edrez-Mart\u00edn R, Men\u00e9ndez Colino R, Alarc\u00f3n T, Tarazona-Santabalbina FJ, Mart\u00ednez-Velilla N, et al. Geriatr\u00eda transversal. Un reto asistencial para el siglo XXI [Cross-speciality geriatrics: a health-care challenge for the 21st century]. Rev Esp Geriatr Gerontol. 2020;55(2):84\u201397. Spanish. https:\/\/doi.org\/10.1016\/j.regg.2019.10.011(Epub 2019 Dec 20. PMID: 31870507).","DOI":"10.1016\/j.regg.2019.10.011"},{"issue":"3","key":"3095_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0090-8258(90)90064-r","volume":"38","author":"JM Heaps","year":"1990","unstructured":"Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38(3):309\u201314. https:\/\/doi.org\/10.1016\/0090-8258(90)90064-r. (PMID: 2227541).","journal-title":"Gynecol Oncol"},{"issue":"9","key":"3095_CR19","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.3390\/cancers14092264","volume":"14","author":"M Virarkar","year":"2022","unstructured":"Virarkar M, Vulasala SS, Daoud T, Javadi S, Lall C, Bhosale P. Vulvar cancer: 2021 revised FIGO staging system and the role of imaging. Cancers (Basel). 2022;14(9):2264. https:\/\/doi.org\/10.3390\/cancers14092264. (PMID: 35565394; PMCID: PMC9102312).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3095_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jogc.2018.07.004","volume":"41","author":"JA Francis","year":"2019","unstructured":"Francis JA, Eiriksson L, Dean E, Sebastianelli A, Bahoric B, Salvador S. No. 370-management of squamous cell cancer of the vulva. J Obstet Gynaecol Can. 2019;41(1):89\u2013101. https:\/\/doi.org\/10.1016\/j.jogc.2018.07.004. (PMID: 30580832).","journal-title":"J Obstet Gynaecol Can"},{"key":"3095_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejca.2016.0O'Donnell7.006","volume":"65","author":"LS Nooij","year":"2016","unstructured":"Nooij LS, van der Slot MA, Dekkers OM, Stijnen T, Gaarenstroom KN, Creutzberg CL, et al. Tumour-free margins in vulvar squamous cell carcinoma: does distance really matter? Eur J Cancer. 2016;65:139\u201349. https:\/\/doi.org\/10.1016\/j.ejca.2016.0O'Donnell7.006. (Epub 2016 Aug 3. PMID: 27497345).","journal-title":"Eur J Cancer"},{"key":"3095_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejca.2016.09.038","volume":"69","author":"L Woelber","year":"2016","unstructured":"Woelber L, Griebel LF, Eulenburg C, Sehouli J, Jueckstock J, Hilpert F, et al. Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gyn\u00e4kologische Onkologie CaRE-1 multicenter study. Eur J Cancer. 2016;69:180\u20138. https:\/\/doi.org\/10.1016\/j.ejca.2016.09.038. (Epub 2016 Nov 10. PMID: 27837710).","journal-title":"Eur J Cancer"},{"issue":"2","key":"3095_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00432-015-2060-9","volume":"142","author":"T Ignatov","year":"2016","unstructured":"Ignatov T, Eggemann H, Burger E, Costa SD, Ignatov A. Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins. J Cancer Res Clin Oncol. 2016;142(2):489\u201395. https:\/\/doi.org\/10.1007\/s00432-015-2060-9. (PMID: 26498775).","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"3095_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ygyno.2013.05.036","volume":"130","author":"AN Viswanathan","year":"2013","unstructured":"Viswanathan AN, Pinto AP, Schultz D, Berkowitz R, Crum CP. Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol. 2013;130(3):545\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2013.05.036. (Epub 2013 Jun 5. PMID: 23747330).","journal-title":"Gynecol Oncol"},{"issue":"9","key":"3095_CR25","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1136\/ijgc-2019-000526","volume":"30","author":"I Zapardiel","year":"2020","unstructured":"Zapardiel I, Iacoponi S, Coronado PJ, Zalewski K, Chen F, Fotopoulou C, Dursun P, et al. VULCAN Study Coinvestigators. Prognostic factors in patients with vulvar cancer: the VULCAN study. Int J Gynecol Cancer. 2020;30(9):1285\u201391. https:\/\/doi.org\/10.1136\/ijgc-2019-000526. (Epub 2020 Jun 22. Erratum in: Int J Gynecol Cancer. 2020 Dec;30(12):2023. PMID: 32571891).","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"3095_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ygyno.2020.06.503","volume":"158","author":"J Yang","year":"2020","unstructured":"Yang J, Delara R, Ghaith S, Newman H, Magrina J, Butler K, et al. Tumor-free margins and local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 2020;158(3):555\u201361. https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.503. (Epub 2020 Jul 3. PMID: 32624236).","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3095_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/IGC.0000000000001195","volume":"28","author":"M Arvas","year":"2018","unstructured":"Arvas M, Kahramanoglu I, Bese T, Turan H, Sozen I, Ilvan S, et al. The role of pathological margin distance and prognostic factors after primary surgery in squamous cell carcinoma of the vulva. Int J Gynecol Cancer. 2018;28(3):623\u201331. https:\/\/doi.org\/10.1097\/IGC.0000000000001195. (PMID: 29324545).","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"3095_CR28","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.ejso.2019.07.005","volume":"45","author":"E Raimond","year":"2019","unstructured":"Raimond E, Delorme C, Ouldamer L, Carcopino X, Bendifallah S, Touboul C, et al. Research group FRANCOGYN. Surgical treatment of vulvar cancer: impact of tumor-free margin distance on recurrence and survival. A multicentre cohort analysis from the francogyn study group. Eur J Surg Oncol. 2019;45(11):2109\u201314. https:\/\/doi.org\/10.1016\/j.ejso.2019.07.005. (Epub 2019 Jul 3. PMID: 31285094).","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"3095_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/jnci\/dju426","volume":"107","author":"S Mahner","year":"2015","unstructured":"Mahner S, Jueckstock J, Hilpert F, Neuser P, Harter P, de Gregorio N, et al. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst. 2015;107(3):426. https:\/\/doi.org\/10.1093\/jnci\/dju426. (PMID: 25618900; PMCID: PMC4356703).","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"3095_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/COC.0000000000000138","volume":"40","author":"G Bogani","year":"2017","unstructured":"Bogani G, Cromi A, Serati M, Uccella S, Donato VD, Casarin J, et al. Predictors and patterns of local, regional, and distant failure in squamous cell carcinoma of the vulva. Am J Clin Oncol. 2017;40(3):235\u201340. https:\/\/doi.org\/10.1097\/COC.0000000000000138. (PMID: 25503429).","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"3095_CR31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5603\/GP.a2018.0073","volume":"89","author":"L Minar","year":"2018","unstructured":"Minar L, Felsinger M, Cihalova M, Zlamal F, Bienertova-Vasku J. Vulvar cancer recurrence\u2014an analysis of prognostic factors in tumour-free pathological margins patients group. Ginekol Pol. 2018;89(8):424\u201331. https:\/\/doi.org\/10.5603\/GP.a2018.0073. (PMID: 30215461).","journal-title":"Ginekol Pol"},{"issue":"3","key":"3095_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ygyno.2019.06.013","volume":"154","author":"R Klapdor","year":"2019","unstructured":"Klapdor R, W\u00f6lber L, Hanker L, Schmalfeldt B, Canzler U, Fehm T, et al. Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study. Gynecol Oncol. 2019;154(3):565\u201370. https:\/\/doi.org\/10.1016\/j.ygyno.2019.06.013. (Epub 2019 Jun 18. PMID: 31227222).","journal-title":"Gynecol Oncol"},{"issue":"12","key":"3095_CR33","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ejso.2015.09.024","volume":"41","author":"G Baiocchi","year":"2015","unstructured":"Baiocchi G, Mantoan H, de Brot L, Badiglian-Filho L, Kumagai LY, Faloppa CC, et al. How important is the pathological margin distance in vulvar cancer? Eur J Surg Oncol. 2015;41(12):1653\u20138. https:\/\/doi.org\/10.1016\/j.ejso.2015.09.024. (Epub 2015 Oct 22. PMID: 26507171).","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"3095_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/1097-0142(20000701)89:1<116::aid-cncr16>3.0.co;2-4","volume":"89","author":"T Maggino","year":"2000","unstructured":"Maggino T, Landoni F, Sartori E, Zola P, Gadducci A, Alessi C, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer. 2000;89(1):116\u201322. https:\/\/doi.org\/10.1002\/1097-0142(20000701)89:1%3c116::aid-cncr16%3e3.0.co;2-4. (PMID: 1089700).","journal-title":"Cancer"},{"issue":"9","key":"3095_CR35","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/j.jogoh.2020.101775","volume":"49","author":"F Pirot","year":"2020","unstructured":"Pirot F, Chaltiel D, Ouldamer L, Touboul C, Raimond E, Carcopino X, et al. Patterns of first recurrence and outcomes in surgically treated women with vulvar cancer: results from FRANCOGYN study group. J Gynecol Obstet Hum Reprod. 2020;49(9):101775. https:\/\/doi.org\/10.1016\/j.jogoh.2020.101775. (Epub 2020 May 8. PMID: 32438137).","journal-title":"J Gynecol Obstet Hum Reprod."},{"issue":"1","key":"3095_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ygyno.2020.05.021","volume":"158","author":"A Gadducci","year":"2020","unstructured":"Gadducci A, Aletti GD. Locally advanced squamous cell carcinoma of the vulva: a challenging question for gynecologic oncologists. Gynecol Oncol. 2020;158(1):208\u201317. https:\/\/doi.org\/10.1016\/j.ygyno.2020.05.021. (Epub 2020 May 25. PMID: 32460996).","journal-title":"Gynecol Oncol"},{"issue":"8","key":"3095_CR37","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/PAS.0000000000000422","volume":"39","author":"ER Holthoff","year":"2015","unstructured":"Holthoff ER, Jeffus SK, Gehlot A, Stone R, Erickson SW, Kelly T, et al. Perineural invasion is an independent pathologic indicator of recurrence in vulvar squamous cell carcinoma. Am J Surg Pathol. 2015;39(8):1070\u20134. https:\/\/doi.org\/10.1097\/PAS.0000000000000422. (PMID: 25786085; PMCID: PMC4503485).","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3095_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ygyno.2018.10.035","volume":"152","author":"MP Salcedo","year":"2019","unstructured":"Salcedo MP, Sood AK, Dos Reis R, Ramalingam P, Chen C, Frumovitz M, et al. Perineural invasion (PNI) in vulvar carcinoma: a review of 421 cases. Gynecol Oncol. 2019;152(1):101\u20135. https:\/\/doi.org\/10.1016\/j.ygyno.2018.10.035. (Epub 2018 Nov 3. PMID: 30396690).","journal-title":"Gynecol Oncol"},{"issue":"11","key":"3095_CR39","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/j.ejso.2019.07.029","volume":"45","author":"F Ferrari","year":"2019","unstructured":"Ferrari F, Forte S, Ardighieri L, Bonetti E, Fernando B, Sartori E, et al. Multivariate analysis of prognostic factors in primary squamous cell vulvar cancer: the role of perineural invasion in recurrence and survival. Eur J Surg Oncol. 2019;45(11):2115\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2019.07.029. (Epub 2019 Jul 29. PMID: 31378417).","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"3095_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ygyno.2016.06.019","volume":"142","author":"JK Yap","year":"2016","unstructured":"Yap JK, Fox R, Leonard S, Ganesan R, Kehoe ST, Dawson CW, et al. Adjacent lichen sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma. Gynecol Oncol. 2016;142(3):420\u20136. https:\/\/doi.org\/10.1016\/j.ygyno.2016.06.019. (Epub 2016 Jul 7. PMID: 27396942).","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3095_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/LGT.0000000000000182","volume":"20","author":"CM Hay","year":"2016","unstructured":"Hay CM, Lachance JA, Lucas FL, Smith KA, Jones MA. Biomarkers p16, human papillomavirus and p53 predict recurrence and survival in early stage squamous cell carcinoma of the vulva. J Low Genit Tract Dis. 2016;20(3):252\u20136. https:\/\/doi.org\/10.1097\/LGT.0000000000000182. (PMID: 26855143).","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"3095_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygyno.2021.11.004","volume":"164","author":"L Woelber","year":"2022","unstructured":"Woelber L, Prieske K, Eulenburg CZ, Corradini S, Petersen C, Bommert M, et al. Adjuvant radiotherapy and local recurrence in vulvar cancer\u2014a subset analysis of the AGO-CaRE-1 study. Gynecol Oncol. 2022;164(1):68\u201375. https:\/\/doi.org\/10.1016\/j.ygyno.2021.11.004. (Epub 2021 Nov 16. PMID: 34794839).","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3095_CR43","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/AOG.0b013e3181b12f99","volume":"114","author":"C Kunos","year":"2009","unstructured":"Kunos C, Simpkins F, Gibbons H, Tian C, Homesley H. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol. 2009;114(3):537\u201346. https:\/\/doi.org\/10.1097\/AOG.0b013e3181b12f99. (PMID: 19701032).","journal-title":"Obstet Gynecol"},{"issue":"5","key":"3095_CR44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/0284186X.2019.1687934","volume":"59","author":"E Serre","year":"2020","unstructured":"Serre E, Raimond E, Diguisto C, Bendifallah S, Body G, Touboul C, et al. Groupe de Recherche FRANCOGYN. Inguino-femoral radiotherapy in vulvar squamous cell carcinoma: clues to revised indications in patients with only one intracapsular lymph node metastasis. Acta Oncol. 2020;59(5):518\u201324. https:\/\/doi.org\/10.1080\/0284186X.2019.1687934. (Epub 2019 Nov 12. PMID: 31718368).","journal-title":"Acta Oncol"},{"issue":"3","key":"3095_CR45","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ygyno.2015.03.056","volume":"137","author":"BS Gill","year":"2015","unstructured":"Gill BS, Bernard ME, Lin JF, Balasubramani GK, Rajagopalan MS, Sukumvanich P, et al. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis. Gynecol Oncol. 2015;137(3):365\u201372. https:\/\/doi.org\/10.1016\/j.ygyno.2015.03.056. (Epub 2015 Apr 11. PMID: 25868965).","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3095_CR46","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.radonc.2018.03.023","volume":"129","author":"NR Rydzewski","year":"2018","unstructured":"Rydzewski NR, Kanis MJ, Donnelly ED, Lurain JR, Strauss JB. Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: A National Cancer Database study. Radiother Oncol. 2018;129(3):534\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2018.03.023. (Epub 2018 Apr 6. PMID: 29631932).","journal-title":"Radiother Oncol"},{"issue":"2","key":"3095_CR47","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ygyno.2009.05.017","volume":"114","author":"G Fons","year":"2009","unstructured":"Fons G, Groenen SM, Oonk MH, Ansink AC, van der Zee AG, Burger MP, et al. Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol Oncol. 2009;114(2):343\u20135. https:\/\/doi.org\/10.1016\/j.ygyno.2009.05.017. (Epub 2009 May 29. PMID: 19481242).","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3095_CR48","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ygyno.2006.06.030","volume":"103","author":"A Parthasarathy","year":"2006","unstructured":"Parthasarathy A, Cheung MK, Osann K, Husain A, Teng NN, Berek JS, et al. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol Oncol. 2006;103(3):1095\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2006.06.030. (Epub 2006 Aug 4. PMID: 16889821).","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3095_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0090-8258(92)90311-6","volume":"45","author":"M Origoni","year":"1992","unstructured":"Origoni M, Sideri M, Garsia S, Carinelli SG, Ferrari AG. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol Oncol. 1992;45(3):313\u20136. https:\/\/doi.org\/10.1016\/0090-8258(92)90311-6. (PMID: 1612509).","journal-title":"Gynecol Oncol"},{"issue":"7","key":"3095_CR50","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S1470-2045(10)70104-2","volume":"11","author":"MH Oonk","year":"2010","unstructured":"Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I, et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 2010;11(7):646\u201352. https:\/\/doi.org\/10.1016\/S1470-2045(10)70104-2. (Epub 2010 May 25. PMID: 20537946).","journal-title":"Lancet Oncol"},{"issue":"1","key":"3095_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ygyno.2015.09.077","volume":"140","author":"NC Te Grootenhuis","year":"2015","unstructured":"Te Grootenhuis NC, van der Zee AG, van Doorn HC, van der Velden J, Vergote I, Zanagnolo V, et al. Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol. 2015;140(1):8\u201314. https:\/\/doi.org\/10.1016\/j.ygyno.2015.09.077.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"3095_CR52","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ygyno.2020.10.008","volume":"160","author":"J van der Velden","year":"2021","unstructured":"van der Velden J, Pleunis N, Barlow E, Zijlmans H, de Hullu J, Hacker NF, et al. Radiotherapy is not indicated in patients with vulvar squamous cell carcinoma and only one occult intracapsular groin node metastasis. Gynecol Oncol. 2021;160(1):128\u201333. https:\/\/doi.org\/10.1016\/j.ygyno.2020.10.008. (Epub 2020 Oct 13. PMID: 33067000).","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3095_CR53","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/IGC.0b013e31823eed4c","volume":"22","author":"L Woelber","year":"2012","unstructured":"Woelber L, Eulenburg C, Choschzick M, Kruell A, Petersen C, Gieseking F, et al. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int J Gynecol Cancer. 2012;22(3):503\u20138. https:\/\/doi.org\/10.1097\/IGC.0b013e31823eed4c.","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl 2","key":"3095_CR54","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/j.ijgo.2015.06.002","volume":"131","author":"NF Hacker","year":"2015","unstructured":"Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. Int J Gynaecol Obstet. 2015;131(Suppl 2):S76-83. https:\/\/doi.org\/10.1016\/j.ijgo.2015.06.002. (Erratum in: Int J Gynaecol Obstet. 2016 Mar; 132(3):365. PMID: 26433678).","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"3095_CR55","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ygyno.2016.12.007","volume":"144","author":"RL O'Donnell","year":"2017","unstructured":"O\u2019Donnell RL, Verleye L, Ratnavelu N, Galaal K, Fisher A, Naik R. Locally advanced vulva cancer: a single centre review of anovulvectomy and a systematic review of surgical, chemotherapy and radiotherapy alternatives. Is an international collaborative RCT destined for the \u201ctoo difficult to do\u201d box? Gynecol Oncol. 2017;144(2):438\u201347. https:\/\/doi.org\/10.1016\/j.ygyno.2016.12.007. (Epub 2016 Dec 27. PMID: 28034465).","journal-title":"Gynecol Oncol"},{"issue":"4","key":"3095_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s1521-6934(03)00051-8","volume":"17","author":"MS Hoffman","year":"2003","unstructured":"Hoffman MS. Squamous-cell carcinoma of the vulva: locally advanced disease. Best Pract Res Clin Obstet Gynaecol. 2003;17(4):635\u201347. https:\/\/doi.org\/10.1016\/s1521-6934(03)00051-8. (PMID: 12965136).","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"3095_CR57","doi-asserted-by":"publisher","first-page":"CD002224","DOI":"10.1002\/14651858.CD002224.pub2","volume":"2011","author":"J Van der Velden","year":"2011","unstructured":"Van der Velden J, Fons G, Lawrie TA. Primary groin irradiation versus primary groin surgery for early vulvar cancer. Cochrane Database Syst Rev. 2011;2011(5):CD002224. https:\/\/doi.org\/10.1002\/14651858.CD002224.pub2. (PMID: 21563133; PMCID: PMC7154218).","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"3095_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s0360-3016(98)00193-x","volume":"42","author":"DH Moore","year":"1998","unstructured":"Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42(1):79\u201385. https:\/\/doi.org\/10.1016\/s0360-3016(98)00193-x. (PMID: 9747823).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3095_CR59","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ygyno.2011.11.003","volume":"124","author":"DH Moore","year":"2012","unstructured":"Moore DH, Ali S, Koh WJ, Michael H, Barnes MN, McCourt CK, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol. 2012;124(3):529\u201333. https:\/\/doi.org\/10.1016\/j.ygyno.2011.11.003. (Epub 2011 Nov 9. PMID: 22079361).","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3095_CR60","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ygyno.2017.06.022","volume":"146","author":"YJ Rao","year":"2017","unstructured":"Rao YJ, Chin RI, Hui C, Mutch DG, Powell MA, Schwarz JK, et al. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database. Gynecol Oncol. 2017;146(3):572\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2017.06.022. (Epub 2017 Jun 27. PMID: 28662775).","journal-title":"Gynecol Oncol"},{"issue":"4","key":"3095_CR61","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/IGC.0000000000000938","volume":"27","author":"D Natesan","year":"2017","unstructured":"Natesan D, Hong JC, Foote J, Sosa JA, Havrilesky L, Chino J. Primary versus preoperative radiation for locally advanced vulvar cancer. Int J Gynecol Cancer. 2017;27(4):794\u2013804. https:\/\/doi.org\/10.1097\/IGC.0000000000000938. (PMID: 28333840).","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"3095_CR62","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ygyno.2019.11.027","volume":"156","author":"A Rishi","year":"2020","unstructured":"Rishi A, Rollins M, Ahmed KA, Hunt DC, Sarkar P, Fernandez DC, et al. High-dose intensity-modulated chemoradiation in vulvar squamous cell carcinoma: Outcome and toxicity. Gynecol Oncol. 2020;156(2):349\u201356. https:\/\/doi.org\/10.1016\/j.ygyno.2019.11.027. (Epub 2019 Nov 23. PMID: 31771865).","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3095_CR63","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ygyno.2019.07.009","volume":"154","author":"L Woelber","year":"2019","unstructured":"Woelber L, Eulenburg C, Kosse J, Neuser P, Heiss C, Hantschmann P, et al. AGO-CaRE 1 investigators. Predicting the course of disease in recurrent vulvar cancer\u2014a subset analysis of the AGO-CaRE-1 study. Gynecol Oncol. 2019;154(3):571\u20136. https:\/\/doi.org\/10.1016\/j.ygyno.2019.07.009. (Epub 2019 Jul 17. PMID: 31324454).","journal-title":"Gynecol Oncol"},{"issue":"4","key":"3095_CR64","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/IGC.0000000000000975","volume":"27","author":"MHM Oonk","year":"2017","unstructured":"Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Br\u00e4nnstr\u00f6m M, Landoni F, et al. European Society of Gynaecological Oncology guidelines for the management of patients with vulvar cancer. Int J Gynecol Cancer. 2017;27(4):832\u20137. https:\/\/doi.org\/10.1097\/IGC.0000000000000975. (PMID: 28441255).","journal-title":"Int J Gynecol Cancer"},{"key":"3095_CR65","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN guidelines). Vulvvar cancer (Squamous cell cancer). Version 1.2022."},{"issue":"3","key":"3095_CR66","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.brachy.2019.01.015","volume":"18","author":"MC Tom","year":"2019","unstructured":"Tom MC, Joshi N, Vicini F, Chang AJ, Hong TS, Showalter TN, et al. The American Brachytherapy Society consensus statement on intraoperative radiation therapy. Brachytherapy. 2019;18(3):242\u201357. https:\/\/doi.org\/10.1016\/j.brachy.2019.01.015. (PMID: 31084904).","journal-title":"Brachytherapy"},{"issue":"6","key":"3095_CR67","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.brachy.2018.09.001","volume":"17","author":"R Mart\u00ednez-Monge","year":"2018","unstructured":"Mart\u00ednez-Monge R, Valtue\u00f1a Peydr\u00f3 G, Cambeiro M, Aramend\u00eda JM, Gimeno M, Santisteban M, et al. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: final results of a Phase II trial. Brachytherapy. 2018;17(6):1045. https:\/\/doi.org\/10.1016\/j.brachy.2018.09.001. (Erratum for: Brachytherapy. 2018 Sep\u2013Oct;17(5):734\u2013741. PMID: 30415833).","journal-title":"Brachytherapy"},{"issue":"9","key":"3095_CR68","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1007\/s12094-021-02601-0","volume":"23","author":"PA Jablonska","year":"2021","unstructured":"Jablonska PA, Cambeiro M, Gimeno M, Aramend\u00eda JM, M\u00ednguez JA, Alc\u00e1zar JL, et al. Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis. Clin Transl Oncol. 2021;23(9):1934\u201341. https:\/\/doi.org\/10.1007\/s12094-021-02601-0. (Epub 2021 Apr 9. PMID: 33835408).","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"3095_CR69","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5114\/jcb.2016.58081","volume":"8","author":"S Kellas-\u015al\u0119czka","year":"2016","unstructured":"Kellas-\u015al\u0119czka S, Bia\u0142as B, Fija\u0142kowski M, Wojcieszek P, Szlag M, Cholewka A, et al. Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer. J Contemp Brachyther. 2016;8(1):32\u201340. https:\/\/doi.org\/10.5114\/jcb.2016.58081. (Epub 2016 Feb 29. PMID: 26985195; PMCID: PMC4793072).","journal-title":"J Contemp Brachyther."},{"issue":"1","key":"3095_CR70","first-page":"387","volume":"36","author":"C Laliscia","year":"2016","unstructured":"Laliscia C, Gadducci A, Montrone S, Tana R, Morganti R, Fabrini MG. Radiotherapy as definitive treatment of patients with primary vulvar carcinoma unfit for surgery and with recurrent vulvar carcinoma after primary radical surgery: results of a retrospective single-center study. Anticancer Res. 2016;36(1):387\u201391 (PMID: 26722070).","journal-title":"Anticancer Res"},{"issue":"5","key":"3095_CR71","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/0360-3016(95)00109-C","volume":"32","author":"S Pohar","year":"1995","unstructured":"Pohar S, Hoffstetter S, Peiffert D, Luporsi E, Pernot M. Effectiveness of brachytherapy in treating carcinoma of the vulva. Int J Radiat Oncol Biol Phys. 1995;32(5):1455\u201360. https:\/\/doi.org\/10.1016\/0360-3016(95)00109-C. (PMID: 7635788).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"3095_CR72","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s12094-021-02557-1","volume":"23","author":"V Lancellotta","year":"2021","unstructured":"Lancellotta V, Macchia G, Garganese G, Fionda B, Fragomeni SM, D\u2019Aviero A, et al. The role of brachytherapy (interventional radiotherapy) for primary and\/or recurrent vulvar cancer: a Gemelli Vul.Can multidisciplinary team systematic review. Clin Transl Oncol. 2021;23(8):1611\u20139. https:\/\/doi.org\/10.1007\/s12094-021-02557-1. (Epub 2021 Mar 1. PMID: 33650029).","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"3095_CR73","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.brachy.2016.10.003","volume":"16","author":"U Mahantshetty","year":"2017","unstructured":"Mahantshetty U, Naga P, Engineer R, Sastri S, Ghadi Y, Upreti U, et al. Clinical outcome of high-dose-rate interstitial brachytherapy in vulvar cancer: a single institutional experience. Brachytherapy. 2017;16(1):153\u201360. https:\/\/doi.org\/10.1016\/j.brachy.2016.10.003. (Epub 2016 Nov 19. PMID: 27876410).","journal-title":"Brachytherapy"},{"issue":"3","key":"3095_CR74","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.brachy.2017.01.005","volume":"16","author":"P Castelnau-Marchand","year":"2017","unstructured":"Castelnau-Marchand P, Escande A, Mazeron R, Bentivegna E, Cavalcanti A, Gouy S, et al. Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinoma. Brachytherapy. 2017;16(3):518\u201325. https:\/\/doi.org\/10.1016\/j.brachy.2017.01.005. (Epub 2017 Mar 3. PMID: 28262516).","journal-title":"Brachytherapy"},{"issue":"7","key":"3095_CR75","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11864-020-00748-6","volume":"21","author":"TW Zhang","year":"2020","unstructured":"Zhang TW, Palma D, D\u2019Souza D, Velker V, Mendez LC. Stereotactic ablative radiotherapy for recurrent or metastatic gynecological cancer: extending lives? Curr Treat Opt Oncol. 2020;21(7):58. https:\/\/doi.org\/10.1007\/s11864-020-00748-6. (PMID: 32533272).","journal-title":"Curr Treat Opt Oncol"},{"issue":"2","key":"3095_CR76","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fonc.2012.00181","volume":"5","author":"CA Kunos","year":"2012","unstructured":"Kunos CA, Brindle J, Waggoner S, Zanotti K, Resnick K, Fusco N, et al. Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies. Front Oncol. 2012;5(2):181. https:\/\/doi.org\/10.3389\/fonc.2012.00181. (PMID: 23227452; PMCID: PMC3514687).","journal-title":"Front Oncol"},{"issue":"3","key":"3095_CR77","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ygyno.2020.10.001","volume":"159","author":"LB Reshko","year":"2020","unstructured":"Reshko LB, Baliga S, Crandley EF, Harry Lomas IV, Richardson MK, Spencer K, et al. Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers. Gynecol Oncol. 2020;159(3):611\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2020.10.001. (Epub 2020 Oct 12. PMID: 33059914).","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3095_CR78","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ygyno.2020.08.010","volume":"159","author":"N Yegya-Raman","year":"2020","unstructured":"Yegya-Raman N, Cao CD, Hathout L, Girda E, Richard SD, Rosenblum NG, et al. Stereotactic body radiation therapy for oligometastatic gynecologic malignancies: a systematic review. Gynecol Oncol. 2020;159(2):573\u201380. https:\/\/doi.org\/10.1016\/j.ygyno.2020.08.010. (Epub 2020 Sep 9. PMID: 32917412).","journal-title":"Gynecol Oncol"},{"issue":"10185","key":"3095_CR79","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(18)32487-5. (Epub 2019 Apr 11. PMID: 30982687).","journal-title":"Lancet"},{"issue":"25","key":"3095_CR80","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol. 2020;38(25):2830\u20138. https:\/\/doi.org\/10.1200\/JCO.20.00818. (Epub 2020 Jun 2. PMID: 32484754; PMCID: PMC7460150).","journal-title":"J Clin Oncol"}],"updated-by":[{"DOI":"10.1007\/s12094-023-03183-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000}}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03095-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-023-03095-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03095-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T14:51:22Z","timestamp":1702133482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-023-03095-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":80,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["3095"],"URL":"https:\/\/doi.org\/10.1007\/s12094-023-03095-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12094-023-03183-9","asserted-by":"object"}]},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"assertion":[{"value":"16 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12094-023-03183-9","URL":"https:\/\/doi.org\/10.1007\/s12094-023-03183-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}